Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
J611285-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $570.90 | |
J611285-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,000.90 |
Synonyms | JTV-803 free base|UNII-P7Z08VK9XO|P7Z08VK9XO|CHEMBL1182177|247131-06-2|4-Piperidinecarboxylic acid, 4-(((2-(aminoiminomethyl)-1,2,3,4-tetrahydro-7-isoquinolinyl)oxy)methyl)-1-(4-pyridinyl)-|CHEMBL216829|JTV803|SCHEMBL6191447|GTPL11364|MISBTXJXWSXZBF-UHFFF |
---|---|
Grade | Moligand™ |
Action Type | INHIBITOR |
Mechanism of action | Inhibitor of coagulation factor X |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 4-[(2-carbamimidoyl-3,4-dihydro-1H-isoquinolin-7-yl)oxymethyl]-1-pyridin-4-ylpiperidine-4-carboxylic acid |
---|---|
INCHI | InChI=1S/C22H27N5O3/c23-21(24)27-10-5-16-1-2-19(13-17(16)14-27)30-15-22(20(28)29)6-11-26(12-7-22)18-3-8-25-9-4-18/h1-4,8-9,13H,5-7,10-12,14-15H2,(H3,23,24)(H,28,29) |
InChi Key | MISBTXJXWSXZBF-UHFFFAOYSA-N |
Canonical SMILES | NC(=N)N1CCc2c(C1)cc(cc2)OCC1(CCN(CC1)c1ccncc1)C(=O)O |
Isomeric SMILES | C1CN(CC2=C1C=CC(=C2)OCC3(CCN(CC3)C4=CC=NC=C4)C(=O)O)C(=N)N |
PubChem CID | 9844392 |
PubChem CID | 9844392 |
---|---|
CAS Registry No. | 247131-06-2 |
ChEMBL Ligand | CHEMBL1182177 |
BindingDB Ligand | 50157335 |
Enter Lot Number to search for COA:
1. Hayashi M, Matsuo A, Nakamoto H, Aisaka K. (2001) Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals.. Eur J Pharmacol, 412 (1): (61-6). [PMID:11166737] |
2. Hayashi M, Hamada A, Okaya Y, Wakitani K, Aisaka K. (2001) Inhibitory effect of JTV-803, a new cyclic guanidine derivative, on factor Xa in vitro and in vivo.. Eur J Pharmacol, 428 (2): (163-8). [PMID:11675032] |
3. Asakura H, Ichino T, Yoshida T, Suga Y, Ontachi Y, Mizutani T, Kato M, Ito T, Yamazaki M, Aoshima K et al.. (2002) Beneficial effect of JTV-803, a new synthetic inhibitor of activated factor X, against both lipopolysaccharide-induced and tissue factor-induced disseminated intravascular coagulation in rat models.. Blood Coagul Fibrinolysis, 13 (3): (233-9). [PMID:11943937] |